Data Sources
Data sources and methodology used by PharmaBenefits.ai.
Primary Data Sources
- CMS NADAC (National Average Drug Acquisition Cost): Published weekly by CMS. Contains 1.6M+ drug pricing records. Reflects the average price retail pharmacies pay to acquire prescription drugs. Our primary data source for drug pricing analysis.
- openFDA Drug NDC Directory: FDA's drug product database providing brand names, generic names, manufacturer information, dosage forms, and pharmacologic classifications.
- Drug Channels Institute: Independent research on pharmaceutical distribution economics, PBM market share, and industry structure.
Regulatory Sources
- FTC Interim Staff Reports: Federal Trade Commission reports on PBM practices and competitive dynamics.
- SEC Filings: Public company disclosures for PBM parent companies.
- CBO Reports: Congressional Budget Office analyses of drug pricing legislation.
Methodology
Drug pricing spreads are calculated as (AWP - NADAC) / AWP. PBM model comparisons are based on published company positioning and industry classification, not specific client contract terms.
Questions about our sources: Contact our editorial team